Back to Results
First PageMeta Content
Business / Earnings before interest / taxes / depreciation and amortization / EV/EBITDA / Net profit / Income / Gross profit / P/E ratio / Profit / Revenue / Generally Accepted Accounting Principles / Finance / Accountancy


Microsoft Word - GSK-3QCY2012_EDITED
Add to Reading List

Document Date: 2012-11-19 01:49:57

Open Document

File Size: 245,52 KB

Share Result on Facebook

Company

GlaxoSmithKline / Aurobindo Pharma / CVS / FY2014E RoCE (%) RoE (%) Alembic Pharma / Bloomberg / Cipla / Accumulate Orchid Chemicals Neutral Ranbaxy* Sun Pharma / Tax Adj. net / Background GlaxoSmithKline Pharmaceuticals / Low GlaxoSmithKline Pharma / PAT Adj. Net / Reuters / /

Country

India / /

/

Event

Product Release / Dividend Issuance / /

IndustryTerm

launched patented products / pharmaceuticals / pharmaceutical player / treatment of epilepsy / herpes treatment / generic products / /

Person

Reddy / /

/

Position

pharmaceutical player / growth driver / /

Product

Zimivir / /

Technology

anti-infectives / CMP / /

SocialTag